Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001079973-09-000413
Filing Date
2009-04-30
Accepted
2009-04-30 08:21:20
Documents
1
Period of Report
2009-04-29

Document Format Files

Seq Description Document Type Size
1 appy_hepler4ex.html 4  
1 appy_hepler4ex.xml 4 13741
  Complete submission text file 0001079973-09-000413.txt   15543
Mailing Address 1585 S. PERRY STREET CASTLE ROCK CO 80104
Business Address 1585 S. PERRY STREET CASTLE ROCK CO 80104 (303) 794-2000
AspenBio Pharma, Inc. (Issuer) CIK: 0001167419 (see all company filings)

EIN.: 841553387 | State of Incorp.: CO | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 815 CLIFF DRIVE MCLEANSVILLE NC 27301
Business Address
HEPLER DOUGLAS I (Reporting) CIK: 0001287149 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33675 | Film No.: 09781159